Also published on: XIV SO 2020, XVI SO 2022, XVII SO 2023
Is this your profile? Do login to access your certificatesAvaliação do pôster - Paloma Souza
Publication: DEVELOPMENT OF NEW COMBINATION STRATEGIES FOR FIRST-LINE CHEMOTHERAPY WITH SELECTIVE CYCLIN-DEPENDENT KINASES (CDK) 4/6 INHIBITORS IN COLORECTAL CANCER
Boa Tarde Alana
Parabéns pelo seu trabalho.
Em determinados protocolos de tratamento de CRC a radioterapia também é utilizada. Vocês pretendem avaliar a combinação da radioterapia com os inibidores?
Dúvidas
Publication: DEVELOPMENT OF NEW COMBINATION STRATEGIES FOR FIRST-LINE CHEMOTHERAPY WITH SELECTIVE CYCLIN-DEPENDENT KINASES (CDK) 4/6 INHIBITORS IN COLORECTAL CANCER
Olá, Alana!
Parabéns pela excelente apresentação!!
Gostaria de saber quais são as suas perspectivas em termos de avaliar os efeitos dos inibidores de CDK4/6 in vivo no câncer colorretal e também se há muitos efeitos colaterais, já que eles já estão sendo usados em CA de mama.
Mais uma vez, parabéns!!
Abraços
XVI SO 2022
DEVELOPMENT OF NEW COMBINATION STRATEGIES OF CHEMOTHERAPY WITH SELECTIVE CYCLIN-DEPENDENT KINASES (CDK) 4/6 INHIBITORS IN COLORECTAL CANCER
XIV SO 2020
Development of new combination strategies for fist-line chemotherapy with selective cyclin-dependent kinases (CDK) 4/6 inhibitors in colorectal cancer and glioblastoma
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper